Morgans, Alicia K. http://orcid.org/0000-0002-6563-4587
Hutson, Thomas
Guan, Alice Kai Dan
Garcia, David http://orcid.org/0000-0003-2097-1675
Zhou, Anna
Drea, Edward
Vogelzang, Nicholas J.
Article History
Received: 11 October 2021
Accepted: 27 June 2022
First Online: 14 July 2022
Declarations
:
: Not applicable.
: Not applicable.
: AKM reported receiving honoraria and advisory fees from Genentech, AstraZeneca, Sanofi, Bayer, Astellas Pharma, Janssen, Advanced Accelerator Applications, Myovant Sciences, and Exelixis; advisory fees from Blue Earth Diagnostics; honoraria from Astellas Scientific and Medical Affairs Inc., Janssen Oncology, Clovis Oncology, and Pfizer; grant support from Astellas Scientific and Medical Affairs Inc., Bayer, Seattle Genetics/Astellas, Genentech, and AstraZeneca; and travel support from Sanofi. TH reports receiving honoraria, advisory fees, grant support, and fees for serving on a speaker’s bureau from Pfizer, Johnson & Johnson, Bristol-Myers Squibb, Eisai, and Exelixis; honoraria, advisory fees, and fees for serving on a speakers bureau from Astellas Pharma; and honoraria and advisory fees from Novartis and Bayer/Onyx. AKG reported being employed by EVERSANA and holding stock in Tyme Technologies and Area Biopharma. DG and AZ reported being employed by EVERSANA. ED reported being employed by and holding stock in Sanofi. NJV reported being employed by and receiving travel and grant support from US Oncology; advisory fees, travel support, and fees for serving on a speakers bureau from Bayer, Genentech/Roche, and AstraZeneca; advisory fees and fees for serving on a speakers bureau from Clovis Oncology and Myovant Sciences; advisory fees, travel support, and honoraria from Pfizer; honoraria and fees for serving as an expert testimony from Novartis; advisory fees, grant support, and honoraria from Merck; travel support and fees for serving on a speakers bureau from Sanofi; advisory fees and holding stock in Caris Life Sciences; advisory fees from Tolero Pharmaceuticals, Astellas Pharma, Boehringer Ingelheim, Corvus Pharmaceuticals, Modra Pharmaceuticals, Janssen Oncology, and Eisai; fees for serving on a speakers bureau from Bristol-Myers Squibb, Seattle Genetics/Astellas. and AVEO; travel support from Exelixis; honoraria from UpToDateand; grant support from Endocyte and Suzhou Kintor Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.